Respiratory dyskinesia due to antiemetic therapy in a cancer patient.
Cancer patients commonly receive neuroleptics as antiemetics to relieve nausea and vomiting induced by chemotherapeutic agents. Respiratory dyskinesia, an infrequent, acute, neuroleptic-induced, dystonic reaction, is a potentially life-threatening entity that responds promptly to anticholinergic medication.
D000328:Adult; D000932:Antiemetics / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001590:Benztropine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004329:Droperidol / Q000008:administration & dosage / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male; D012119:Respiration / Q000187:drug effects
D000932:Antiemetics; D001590:Benztropine; D004329:Droperidol